
ARN-2966
CAS No. 102212-26-0
ARN-2966( ARN2966 | ARN 2966 )
Catalog No. M10104 CAS No. 102212-26-0
ARN-2966 is a potent, BBB penetrant post-transcriptional modulator of APP expression in transfected CHO cells that produce amyloid precursor protein (APP).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 65 | In Stock |
![]() ![]() |
10MG | 110 | In Stock |
![]() ![]() |
25MG | 222 | In Stock |
![]() ![]() |
50MG | 357 | In Stock |
![]() ![]() |
100MG | 530 | In Stock |
![]() ![]() |
500MG | 1152 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameARN-2966
-
NoteResearch use only, not for human use.
-
Brief DescriptionARN-2966 is a potent, BBB penetrant post-transcriptional modulator of APP expression in transfected CHO cells that produce amyloid precursor protein (APP).
-
DescriptionARN-2966 is a potent, BBB penetrant post-transcriptional modulator of APP expression in transfected CHO cells that produce amyloid precursor protein (APP); reduces expression of APP with resultant lower production of Aβ; improves the memory and reduces Aβ in AD transgenic mice; orally active.
-
In Vitro——
-
In Vivo——
-
SynonymsARN2966 | ARN 2966
-
PathwayOthers
-
TargetAmyloids
-
RecptorAmyloids
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number102212-26-0
-
Formula Weight200.2365
-
Molecular FormulaC12H12N2O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 43.4 mg/mL
-
SMILESC1=CC=C(C(=C1)NCC2=CC=CC=N2)O
-
Chemical NamePhenol, 2-[(2-pyridinylmethyl)amino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ayodeji Asuni, et al. DOI: http://dx.doi.org/10.1016/j.jalz.2013.08.025
molnova catalog



related products
-
GSK-3039294
GSK-3039294 is an orally available small molecule inhibitor of serum amyloid P component (SAP).
-
TDI-2760
TDI-2760 si a small molecule Aβ-aggregation inhibitor that not only shows a strong inhibitory efficacy toward the Aβ-fibrinogen interaction.
-
ALZ-801
ALZ-801 is an orally available, valine-conjugated prodrug of tramiprosate, a small-molecule β-amyloid (Aβ) anti-oligomer and aggregation inhibitor for the treatment of Alzheimer's disease.